🔎 Trials Near Me

Почетна › Беркитов лимфом › Misuri › Kansas City

Kliničke studije za Беркитов лимфом u gradu Kansas City, MO

10 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Kansas City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Тражи се учесникФаза 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Children's Mercy Hospitals and Clinics, Kansas City
Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 ми удаљено
Узраст од 18 до 39 · Оба пола · Ажурирано 3. 11. 2026. · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • Children's Mercy Hospital ( Site 1024), Kansas City
6 Months – 25 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT06395103

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2
  • Children's Mercy Hospitals and Clinics, Kansas City
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

Тражи се учесникФаза 1/2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07069699

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3
  • Children's Mercy Hospitals and Clinics, Kansas City
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

Тражи се учесникФаза 1
  • University of Kansas Cancer Center, Westwood · 5 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 14. 5. 2026. · NCT06879340

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Тражи се учесникФаза 2
  • Children's Mercy Hospital, Kansas City
Узраст од 1 до 25 · Оба пола · Ажурирано 4. 5. 2025. · NCT03509961

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Kansas City

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.